We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this ...

Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abbott Laboratories (ABT – Research Report) and ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the trades showed up on publicly ...